You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藥易購(300937.SZ):擬參投湖州見素藥易購創業投資合夥企業
格隆匯 10-13 18:32

格隆匯10月13日丨藥易購(300937.SZ)公佈,公司於2023年10月13日召開第三屆董事會第十五次會議,審議通過了《關於參與投資私募產業基金的議案》,同意公司與廣州見素私募基金管理有限公司、湖州市見素易購企業管理合夥企業(有限合夥)、湖州吳興旅遊建設發展有限公司簽署《湖州見素藥易購創業投資合夥企業(有限合夥)之合夥協議》,藥易購擬作為有限合夥人參與投資湖州見素藥易購創業投資合夥企業(有限合夥)(暫定名,具體以相關行政登記為準,以下簡稱“本合夥企業”或者“產業基金”),產業基金預計募集資金合計人民幣14,101萬元,其中藥易購擬以自有資金出資4200萬元。

本次基金全部投資於醫療大健康領域,其中主要投資於MAH批文及轉化平台(Marketing Authorization Holder,藥品上市許可持有人,即藥品批准文號的所有權人),其他投資於未上市成長性、創新性企業的資金比例不超過40%,亦可對創投類/股權類基金份額進行投資(如有),並相應獲得股東權益,為被投企業提供投後增值服務,以期所投資創業企業發展成熟後,通過股權轉讓或上市退出等方式獲取資本增值收益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account